February 2020 FDA Recall Potassium Chloride by Strides Pharma Science Limited
D-1029-2020 - Failed Tablet/Capsules Specifications

This Class III drug recall was voluntarily initiated by Strides Pharma Science Limited on February 17, 2020 for the product Potassium Chloride. The FDA reported the reason for recall as failed tablet/capsules specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1029-2020

Reason for Recall
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Initiated
02-17-2020
Reported
03-25-2020
Quantity
2576 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Strides Pharma Science Limited
Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08

Batch or Lot Expiration Information

Lot# : 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021